Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy
{{output}}
Annually, approximately 3.5 % of the world's population dies of cirrhosis or liver cancer, and the burden of liver disease is steadily expanding owing to multiple factors such as alcohol consumption, irrational diets, viral transmission, and exposure to drugs... ...
